ATNM
Actinium Pharmaceuticals Inc
1.20$
+0.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +251.3% | -15.3% | -18.6% | -18.8% | -21.6% | +468.9% | +21.1% | +42.1% | -28.7% | -5.6% | -32.7% | |
| – | +257.5% | -15.4% | -20.3% | -19.7% | -29.6% | +543.6% | +22.8% | +39.1% | -29.5% | -4.8% | -33.7% | |
| – | +282.3% | -20.0% | -15.2% | -21.4% | -32.3% | +587.4% | +22.4% | +39.9% | -29.6% | -4.9% | -34.2% | |
| – | +281.7% | -20.0% | -15.2% | -21.4% | -32.3% | +587.4% | +22.4% | +39.9% | -29.6% | -4.9% | -34.2% | |
| – | -16.9% | -16.5% | -35.2% | +107.1% | +860.9% | -9.7% | -38.0% | +361.3% | – | – | – | |
| – | -51.4% | -2.0% | +3.2% | +30.2% | -0.8% | -15.7% | +34.8% | +597.2% | -5.5% | -2.1% | -0.5% | |
| – | -51.4% | -2.0% | +3.2% | +29.9% | -11.9% | -10.8% | +43.5% | +55.4% | -20.1% | -4.1% | -2.2% | |
| – | -6.3% | +13.2% | -94.7% | +1,466.0% | +199.3% | -42.8% | -28.1% | +62.2% | +8.6% | +7.2% | +24.5% | |
| – | -35.5% | +184.6% | +10.9% | +25.0% | -20.9% | -5.6% | +27.5% | +83.0% | -21.5% | -4.8% | – | |
| – | – | -18.0% | -24.1% | -35.5% | -36.0% | +986.4% | +19.9% | -9.6% | -45.3% | -10.0% | -76.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +39.5% | +27.0% | +37.8% | +58.9% | +40.8% | +143.9% | +69.5% | +17.4% | +10.2% | +13.0% | +3.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.